Lexeo Therapeutics, Inc. Common StockLXEONASDAQ
LOADING
|||
Revenue Growth Under Pressure
Below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
0.00%
↓ 100% below average
Average (14q)
78.56%
Historical baseline
Range
High:1335.14%
Low:-100.00%
Volatility
1826.8%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | -100.00% |
| Q3 2022 | 1335.14% |
| Q2 2022 | -56.75% |
| Q1 2022 | 0.00% |